About
Dr Laura Kenny is a Consultant in Medical Oncology and she specialises in breast cancer. She trained in medicine at Queen's University Belfast and after following initial registrar training, she moved to London to study for a PhD in translational molecular imaging in the Cyclotron Building, Imperial College London. Her NHS clinical practice is based at Charing Cross and Hammersmith Hospitals (part of Imperial College Healthcare NHS Trust) and she also sees patients privately. In addition, Dr Kenny is a Clinical Senior Lecturer at Imperial College.
Dr Kenny was awarded a Westminster Medical School Oncology Trustee's fellowship and her research has focused on the use of novel PET radiotracers for studying proliferation (fluorothymidine (FLT)), angiogenesis (fluciclatide (AH-111585), and choline metabolism in breast cancer patients. Her work has been published in Cancer Research, Clinical Cancer Research, the Journal of Nuclear Medicine, and the European Journal of Molecular Imaging and Nuclear Medicine.
She was awarded a prestigious NIHR/MRC clinician scientist fellowship in 2010, with the aim of the project being to establish new methods for defining the imaging phenotype in patients, which will help predict drug resistance and drug sensitivity at early timepoints to established and novel cancer therapeutic agents. Her research has been recognised by the American Association of Cancer Research (Young Investigator Award), American Society of Clinical Oncology (Merit Award), British Cancer Research Meeting (Translational Research Award), and she also won the McElwain prize.
Dr Kenny was also appointed as Director of Early Phase Clinical Trials in Cancer, where her aim is to expedite clinical drug development with novel approaches to clinical trials. She was also awarded an MRC DPFS project grant to study a new Affibody probe which will target her2 expression in breast cancer, this will be a first in man study and involves collaboration with four leading oncology centres in the UK.
Diseases, Medical Tests and Treatments
• Chemotherapy
• Breast Cancer
Dr Kenny was awarded a Westminster Medical School Oncology Trustee's fellowship and her research has focused on the use of novel PET radiotracers for studying proliferation (fluorothymidine (FLT)), angiogenesis (fluciclatide (AH-111585), and choline metabolism in breast cancer patients. Her work has been published in Cancer Research, Clinical Cancer Research, the Journal of Nuclear Medicine, and the European Journal of Molecular Imaging and Nuclear Medicine.
She was awarded a prestigious NIHR/MRC clinician scientist fellowship in 2010, with the aim of the project being to establish new methods for defining the imaging phenotype in patients, which will help predict drug resistance and drug sensitivity at early timepoints to established and novel cancer therapeutic agents. Her research has been recognised by the American Association of Cancer Research (Young Investigator Award), American Society of Clinical Oncology (Merit Award), British Cancer Research Meeting (Translational Research Award), and she also won the McElwain prize.
Dr Kenny was also appointed as Director of Early Phase Clinical Trials in Cancer, where her aim is to expedite clinical drug development with novel approaches to clinical trials. She was also awarded an MRC DPFS project grant to study a new Affibody probe which will target her2 expression in breast cancer, this will be a first in man study and involves collaboration with four leading oncology centres in the UK.
Diseases, Medical Tests and Treatments
• Chemotherapy
• Breast Cancer
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Laura Kenny
Education & training
-
2008–2014 MD · Medicine and Surgery
-
2014–2018 Residency · Oncologia
-
2018–2019 Fellowship · Subspecialty training
Career & appointments
-
2018-09–2019-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncologia
Malpractice insurance:
HDI Global · 3,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 86 |
| Annual physical exam | 99395 | 1,496 |
| Vaccination administration | 90471 | 1,856 |
| Minor procedure (skin) | 17110 | 879 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 180.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 450.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 19 · i10: 11
-
European registry analysis of Oncologia outcomes
DOI: 10.3003/euroclin.2025.0 · PMID: 31994736 · cited by 22
-
Outcomes of Oncologia in adults — a multi-centre cohort
DOI: 10.2344/euroclin.2024.1 · PMID: 36057179 · cited by 116
Invited talks
- Practical updates in Oncologia European Annual Congress (Oncologia) · Vienna · 2024 · invited
- Single-centre experience in Oncologia National Society Meeting · London · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncologia — London · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2019
- national college of family doctors — Member · since 2019
- European Union of Medical Specialists (UEMS) — Member · since 2019
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncologia
- Awareness When should you see a oncologia?
For international patients
- Coordinator
- Patient liaison · dr.laura.kenny@euroclinics.example
Location
1 tagSimilar specialists
Browse all →
Dr. Mohammadhassan Heidari
Oncologia · Dubai
Dr Daniel Krell
Oncologia · London
Dr Amna Sheri
Oncologia · London
Dr. Batool Aboud
Oncologia · Dubai
Professor Paul Ellis
Oncologia · London
Professor Wasat Mansoor
Oncologia · Manchester
Dr Lucy Brazil
Oncologia · London
Dr Ramin Behzadigohar
Oncologia · Frankston